Combination of six-minute walk test (6MWT) and exhaled carbon monoxide (eCO) measurement in patients with exogenous allergic alveolitis (EAE) and idiopathic pulmonary fibrosis (IPF)

Combination of six-minute walk test (6MWT) and exhaled carbon monoxide (eCO) measurement in patients with exogenous allergic alveolitis (EAE) and idiopathic pulmonary fibrosis (IPF) – test of a new approach

E. I. Shmelev, A. S. Zayceva, I. V. Sivokozov (Moscow, Russian Federation)

Source: Annual Congress 2007 - Clinical aspects of idiopathic pulmonary fibrosis

Session: Clinical aspects of idiopathic pulmonary fibrosis
Session type: Thematic Poster Session
Number: 3441

Disease area: Interstitial lung diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. I. Shmelev, A. S. Zayceva, I. V. Sivokozov (Moscow, Russian Federation). Combination of six-minute walk test (6MWT) and exhaled carbon monoxide (eCO) measurement in patients with exogenous allergic alveolitis (EAE) and idiopathic pulmonary fibrosis (IPF) – test of a new approach. Eur Respir J 2007; 30: Suppl. 51, 3441

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Combination of six-minute walk test (6MWT) and exhaled carbon monoxide (eCO) measurement in patients with sarcoidosis – test of a new approach Source: Eur Respir J 2007; 30: Suppl. 51, 117s Year: 2007
Clinical significance of falling oxygen saturation per walking distance (ΔSaO2/6MWD) during six minute walk test (6MWT) in idiopathic pulmonary fibrosis (IPF) Source: International Congress 2015 – IPF: clinical aspects Year: 2015
6-minute walk test (6MWT) in patients with idiopathic pulmonary fibrosis (IPF): Confirmation of the minimal clinically important difference (MCID) Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012
Analysis of oxygen saturation (O2 sat.) During the six minutes walk distance (6MWD) test in chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases Year: 2009
Six minute walk distance (6MWD) and pulmonary diffusing capacity (DLCO) in patients with COPD Source: International Congress 2015 – COPD: notable points Year: 2015
A six minute walking test (6MWT) derived index (O2-GAP) predicts mortality in IPF Source: International Congress 2015 – IPF: clinical aspects II Year: 2015
Is Fractional exhaled nitric oxide (FeNO) test reliable in the differentiation of chronic obstructive pulmonary disease (COPD) and ACOS (asthma-COPD overlap syndrome)? Source: International Congress 2017 – Lung function testing in different patient categories Year: 2017
Comparison of pulmonary function tests (PFTs) and 6-minute walk test (6MWT) in patients with lymphangioleiomyomatosis (LAM) Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020
Effect of continued pirfenidone treatment following a ≥ 15% decline in 6-minute walk distance (6MWD) in patients with idiopathic pulmonary fibrosis (IPF): Pooled analysis from 3 pivotal studies Source: International Congress 2016 – New and old therapies for chronic lung diseases Year: 2016
Relationship of cardiopulmonary exercise testing (CPET) and lung function in idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2007; 30: Suppl. 51, 120s Year: 2007
Echocardiographic findings in severe chronic obstructive pulmonary disease (COPD) patients who desaturate during 6-minute walking test (6MWT) Source: Annual Congress 2011 - Clinical physiology for clinical problems Year: 2011
Mediation of the effect of airflow obstruction upon six minute Walking distance (6MWD) by cytokine IL6 plasma levels in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD treatment and others Year: 2013
Influence of hospitalizations because of COPD exacerbation in the six-minute walk test (6MWT) Source: International Congress 2015 – COPD: interesting notes Year: 2015
Exhaled breath condensate (EBC): what is sampled and how should it be collected? (recommendations and open issues) Source: Annual Congress 2007 - ERS/ATS joint symposium: the report of the ERS/ATS Task Force on Exhaled Breath Condensate Year: 2007
The six minute walk test (6MWT) can predict O₂ flows required to prevent exercise induced O₂ desaturation in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical issues in idiopathic pulmonary fibrosis Year: 2010
Test-retest reliability for the 30-meter walk test (30mWT) in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - Exercise training: new groups, new methods and outcomes Year: 2010
Stops and its correlation with new measurements during the six-minute walk test in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Clinical exercise physiology in health and disease Year: 2016
Carbon monoxide diffusing capacity (DLCO) in COVID-19 survivors versus idiopathic pulmonary fibrosis (IPF): the pathogenetic features Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases Year: 2021
Change in 6 minute walk distance (6MWD) following a familiarisation test and exercise training in patients with chronic obstructive pulmonary disease (COPD): influence of disability Source: Annual Congress 2008 - Rehabilitation and influencing factors Year: 2008
Effect of formoterol addition on dynamic hyperinflation during 6-minute walk test (6MWT) in moderate to severe COPD Source: Annual Congress 2007 - Treatment of COPD Year: 2007